Song 2020b Study characteristics Patient Sampling Purpose: to develop a tool for early diagnosis of SARS‐CoV2‐infected patientsDesign: cross‐sectional, retrospective, single‐centre (2 time frame study: training ‐ validation data set)Recruitment: 1311 patients who presented to the First Affiliated Hospital, School of Medicine, Zhejiang University with at least 1 SARS‐CoV‐2 RT‐PCR testSample size: n = 304 (73 cases) (= subset of the study including training dataset only)n = 95 (18 cases) (= validation dataset)Inclusion criteriaAll RT‐PCR‐positive cases; 1311 All RT‐PCR‐negative patients who came to the First Affiliated Hospital, School of Medicine, Zhejiang University and performed with at least 1 SARS‐CoV‐2 nucleic acid detection for analysis RT‐PCR First 60% of negative outpatients sorted by 'Z‐A' based on Chinese first name from Qingchun District (training dataset), and then final 40% who presented (validation dataset) Exclusion criteriaAsymptomatic patients without history of exposure but had strong willingness for detection Patients with "important" missing data Patient characteristics and setting Facility cases: positive SARS‐CoV‐2Facility controls: negative SARS‐CoV‐2Country: ChinaDates: 20 January 2020‐05 February 2020Symptoms and severity: in positives: non‐severe (n = 31), including mild or moderate patients to severe (n = 42) including severe or critical patientsMild: patients had no pneumonia on imaging (CT) Moderate: patients with symptoms and imaging examination showing pneumonia Severe: patients meet any of the following: respiratory rate ≥ 30/min resting pulse SpO2 ≤ 93% PaO2/FiO2 ≤ 300 mmHg (1 mmHg = 0.133 kPa) multiple pulmonary lobes showing more than 50% progression of lesion in 24‐48 hours on imaging Critical: patients meet any of the following: respiratory failure requiring mechanical ventilation shock combination of other organ failure that requires admission to ICU Demographics: M/F: cases 46/27, controls 104/127
median age: cases 53.0 years (43.5‐62.0) controls 34 years (29‐49)Exposure history: Wuhan‐related exposure and or close contact to confirmed COVID‐19 case: cases 40.7%, controls 57.5% Index tests Fever Cough Expectoration Headache Myalgia or fatigue Chill Rhinobyon/rhinorrhoea Pharyngalgia Dyspnoea Diarrhoea Nausea/vomiting Temperature (maximum) Body temperature SpO2 Respiratory rate Heart rate Mean arterial pressure Target condition and reference standard(s) TC: SARS‐CoV‐2 infection RS: RT‐PCR for SARS‐CoV‐2 (test not specified: "using emergency use authorization approved SARS‐CoV‐2 assays)" (following WHO protocol, 2 target RT‐PCR (ORF1 and N) Flow and timing Within 3 h for RS, first in‐hospital stay for index tests Comparative   Notes   Methodological quality Item Authors' judgement Risk of bias Applicability concerns DOMAIN 1: Patient Selection Was a consecutive or random sample of patients enrolled? No     Was a case‐control design avoided? Yes     Did the study avoid inappropriate exclusions? Unclear     Did the study avoid inappropriate inclusions? Yes     Could the selection of patients have introduced bias?   Unclear risk   Are there concerns that the included patients and setting do not match the review question?     Low concern DOMAIN 2: Index Test (All tests) Were the index test results interpreted without knowledge of the results of the reference standard? Unclear     If a threshold was used, was it pre‐specified? No     Could the conduct or interpretation of the index test have introduced bias?   High risk   Are there concerns that the index test, its conduct, or interpretation differ from the review question?     Low concern DOMAIN 3: Reference Standard Is the reference standards likely to correctly classify the target condition? Yes     Were the reference standard results interpreted without knowledge of the results of the index tests? Yes     Could the reference standard, its conduct, or its interpretation have introduced bias?   Low risk   Are there concerns that the target condition as defined by the reference standard does not match the question?     Low concern DOMAIN 4: Flow and Timing Was there an appropriate interval between index test and reference standard? Yes     Did all patients receive the same reference standard? Yes     Were all patients included in the analysis? Yes     Could the patient flow have introduced bias?   Low risk